DUBLIN--(BUSINESS WIRE)--The "Women's Health Diagnostics Market by Application (Biopsy, Cervical & Ovarian Cancer Testing, PAP Smear, HPV, TORCH, Prenatal Testing, Hepatitis, Ultrasound, Obstetrics), End User (Hospitals, Clinics, Home Care), COVID-19 Impact - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.
The global women's health diagnostics market is projected to reach USD 36.6 billion by 2025 from USD 25.0 billion in 2020, at a CAGR of 7.9% during the forecast period.
In the past decade, the demand for various health diagnostic tests has increased significantly across the globe. Currently, the market is mainly driven by growing awareness about various health-related disorders, rising incidence of chronic and lifestyle disorders, and the high prevalence of infectious diseases such as HIV and hepatitis in women across the globe.
The increasing adoption of POC diagnostic testing and the growth in the number of diagnostic and imaging centers are also expected to support the growth of this market during the forecast period.
This report provides insights into the following pointers:
- Market Penetration: Comprehensive information on product portfolios offered by the top players in the global women's health diagnostics market. The report analyzes this market by application, and end user
- Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global women's health diagnostics market
- Market Development: Comprehensive information on the lucrative emerging markets by application, and end user
- Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global women's health diagnostics market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in the global women's health diagnostics market.
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
4.1 Women's Health Diagnostics Market Overview
4.2 APAC: Pregnancy & Fertility Testing Market, by Type (2019)
4.3 Geographic Snapshot of the Women's Health Diagnostics Market
4.4 Geographic Mix: Women's Health Diagnostics Market
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Market Drivers
5.2.1.1 High Prevalence of Infectious Diseases in Women
5.2.1.2 Rising Incidence of Chronic and Lifestyle-Related Disorders in Women
5.2.1.3 Increasing Awareness About Fertility Testing in Women and Initiatives by Government and Health Organizations
5.2.1.4 Increased Adoption of Poc and Rapid Diagnostic Tests
5.2.1.5 Growth in the Number of Private Diagnostic and Imaging Centers
5.2.1.6 Public-Private Partnerships Are Expected to Enhance Infrastructure in Diagnostic Imaging Centers
5.2.2 Market Restraints
5.2.2.1 High Cost of Diagnostic Imaging Systems and Procedures
5.2.2.2 Shortage of Skilled Laboratory Technicians
5.2.3 Market Opportunities
5.2.3.1 Improving Healthcare Infrastructure in Emerging Markets
5.2.3.2 Growing Number of Regulatory Approvals for Immunoassay Diagnostic Techniques
5.2.4 Market Challenges
5.2.4.1 Stringent Regulatory Guidelines
5.2.4.2 Increasing Adoption of Refurbished Diagnostic Imaging Systems
5.3 COVID-19 Impact on the Women's Health Diagnostics Market
6 Women's Health Diagnostics Market, by Application
6.1 Introduction
6.2 Breast Cancer Testing
6.3 Infectious Disease Testing
6.4 Cervical Cancer Testing
6.5 Std Testing
6.6 Osteoporosis Testing
6.7 Prenatal Genetic Screening & Carrier Testing
6.8 Pregnancy & Fertility Testing
6.9 Ultrasound Tests
6.10 OVC Testing
7 Women's Health Diagnostics Market, by End-user
7.1 Introduction
7.2 COVID-19 Impact on the Women's Health Diagnostics Market, by End-user
7.3 Hospitals & Clinics
7.4 Diagnostic & Imaging Centers
7.5 Home Care Settings
8 Women's Health Diagnostics Market, by Region
9 Competitive Landscape
9.1 Overview
9.2 Geographical Assessment of the Major Players in the Women's Health Diagnostics Market
9.3 Revenue Share Analysis of Top Players
9.4 Market Share Analysis
9.5 Competitive Leadership Mapping
9.5.1 Stars
9.5.2 Emerging Leaders
9.5.3 Pervasive Players
9.5.4 Emerging Companies
9.6 Competitive Leadership Mapping for Start-Ups
9.6.1 Progressive Companies
9.6.2 Dynamic Companies
9.6.3 Starting Blocks
9.6.4 Responsive Companies
9.7 Competitive Situation and Trends
9.7.1 Product Launches & Enhancements
9.7.2 Expansions
9.7.3 Acquisitions
9.7.4 Other Strategies
10 Company Profiles
- Abbott Laboratories
- Becton, Dickinson and Company
- Biomerieux Sa
- Cardinal Health, Inc.
- Carestream Health, Inc.
- Cook Medical, Inc.
- Dialab Gmbh
- F. Hoffmann-La Roche Ltd.
- Fujifilm Holdings Corporation
- General Electric Company
- Guided Therapeutics, Inc.
- Hologic, Inc.
- Koninklijke Philips N.V.
- Medgyn Products, Inc.
- Neurologica Corporation
- Osteometer Meditech, Inc.
- Perkinelmer, Inc.
- Quest Diagnostics Incorporated
- Siemens Ag
- Supersonic Imagine
For more information about this report visit https://www.researchandmarkets.com/r/ywhvi6
